Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy.
Watanabe S, Shimoi T, Nishikawa T, Kawachi A, Okuma HS, Tokura M, Yazaki S, Mizoguchi C, Arakaki M, Saito A, Kita S, Yamamoto K, Kojima Y, Sudo K, Noguchi E, Yoshida A, Kawai A, Fujiwara Y, Yonemori K.
Watanabe S, et al. Among authors: yonemori k.
Sci Rep. 2023 Jul 3;13(1):10734. doi: 10.1038/s41598-023-37616-w.
Sci Rep. 2023.
PMID: 37400504
Free PMC article.